NCT00207168View on ClinicalTrials.gov

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
AIDS
Interventions
BEHAVIORAL

Compliance

Sponsors

Collaborators (1)

Dohme Australia
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Dohme Australia

UNKNOWN

lead

Bristol-Myers Squibb

INDUSTRY